Skip to main content
JNJ $270.31 +0.03%
JNJ logo
JNJ · Johnson & Johnson
Track JNJ — free
Market Cap
$641.80B
Shares
2.41B
All earnings calls

Earnings call · FY2026 Q2

Johnson & Johnson (JNJ) Q2 2026 Earnings Call

Concluded Oct 14, 2025
Oct 14, 2025 0 turns
Period
FY2026 Q2
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release stays in one workspace.

Research coverage

1 live source

Open each available source without leaving this research workspace.

Revenue $25.31B +6.6% YoY
Diluted EPS $2.27 -0.9% YoY
Gross margin 68.2% +0.3 pp YoY
Net income $5.53B -0.1% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Innovative Medicine$16.38B +7.8% YoY
MedTech$8.93B +4.5% YoY

Capital returned

Buybacks · derived
$221.00M
Full-screen source Call document